About
This medication is a triple-combination oral antidiabetic agent specifically formulated for the comprehensive management of type 2 diabetes mellitus in adults. It typically comprises Glimepiride, a sulfonylurea that enhances insulin secretion from pancreatic beta cells; Metformin, a biguanide that primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues; and Voglibose, an alpha-glucosidase inhibitor that delays the absorption of carbohydrates from the gastrointestinal tract. This multi-pronged approach targets distinct pathophysiological defects in glucose regulation, including impaired insulin secretion, insulin resistance, and post-prandial glucose spikes. By addressing these multiple facets of diabetes, the combination therapy leads to more effective and sustained glycemic control, helping patients achieve their target HbA1c levels. It is indicated for adult patients whose blood sugar levels are not adequately controlled by monotherapy or dual therapy with other antidiabetic agents, providing a robust option for complex cases.
Uses
- Management of type 2 diabetes mellitus.
- To achieve better glycemic control in adults.
- When monotherapy or dual therapy is insufficient.
- As an adjunct to diet and exercise.
Directions For Use
Take orally with meals, as directed by your physician, usually with the first bite of food to maximize the effect of voglibose.
Benefits
- Comprehensive blood sugar control through multiple mechanisms.
- Reduces post-meal glucose spikes effectively.
- Improves insulin sensitivity and secretion.
- Helps in achieving target HbA1c levels.
- May reduce the risk of long-term diabetic complications.
- Offers convenience of a single tablet for multiple therapies.
Side Effects
- Hypoglycemia (low blood sugar)
- Nausea
- Diarrhea
- Abdominal pain/discomfort
- Flatulence
- Bloating
- Metallic taste
- Headache
- Dizziness
- Lactic acidosis (rare, serious with Metformin)
- Vitamin B12 deficiency (with Metformin)
- Skin rash
Safety Measures
- Alcohol - Avoid excessive alcohol consumption due to increased risk of hypoglycemia and potential for lactic acidosis with Metformin.
- Pregnancy - Generally not recommended during pregnancy. Insulin therapy is usually preferred for glycemic control in pregnant women with diabetes.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and affect the infant.
- Liver - Contraindicated in severe liver impairment due to increased risk of lactic acidosis (Metformin) and altered drug metabolism. Use with caution in mild to moderate cases.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to Metformin accumulation and increased risk of lactic acidosis. Dose adjustment required for moderate impairment.
- Lung - Use with caution in conditions causing hypoxia (e.g., severe respiratory failure) as it may increase the risk of lactic acidosis with Metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!